Dr Peta Dennington

Lecturer
Medicine, Central Clinical School
Australian Red Cross Blood Service

Telephone 0292342311

Map

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Hirani, R., Wong, J., Diaz, P., Mondy, P., Hogan, C., Dennington, P., Pink, J., Irving, D. (2017). A national review of the clinical use of group O D- red blood cell units. Transfusion, 57(5), 1254-1261. [More Information]
  • Dyer, W., Tan, J., Day, T., Kiers, L., Kiernan, M., Yiannikas, C., Reddel, S., Ng, K., Mondy, P., Dennington, P., Dos Remedios, C., Vucic, S., et al (2016). Immunomodulation of inflammatory leukocyte markers during intravenous immunoglobulin treatment associated with clinical efficacy in chronic inflammatory demyelinating polyradiculoneuropathy. Brain and Behavior, 6(10), 1-11. [More Information]
  • Smith, S., Dennington, P., Cooper, A. (2010). The use of intravenous immunoglobulin for treatment of dermatological conditions in Australia: A review. Australasian Journal of Dermatology, 51(4), 227-237. [More Information]

2017

  • Hirani, R., Wong, J., Diaz, P., Mondy, P., Hogan, C., Dennington, P., Pink, J., Irving, D. (2017). A national review of the clinical use of group O D- red blood cell units. Transfusion, 57(5), 1254-1261. [More Information]

2016

  • Dyer, W., Tan, J., Day, T., Kiers, L., Kiernan, M., Yiannikas, C., Reddel, S., Ng, K., Mondy, P., Dennington, P., Dos Remedios, C., Vucic, S., et al (2016). Immunomodulation of inflammatory leukocyte markers during intravenous immunoglobulin treatment associated with clinical efficacy in chronic inflammatory demyelinating polyradiculoneuropathy. Brain and Behavior, 6(10), 1-11. [More Information]

2010

  • Smith, S., Dennington, P., Cooper, A. (2010). The use of intravenous immunoglobulin for treatment of dermatological conditions in Australia: A review. Australasian Journal of Dermatology, 51(4), 227-237. [More Information]

To update your profile click here. For support on your academic profile contact .